These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 17066738

  • 1. The pathogenetic aspects and gene polymorphisms of IgA nephropathy.
    Maixnerová D, Merta M, Reiterová J, Stekrová J, Rysavá R, Obeidová H, Tesar V.
    Prague Med Rep; 2006; 107(2):171-88. PubMed ID: 17066738
    [Abstract] [Full Text] [Related]

  • 2. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation].
    Matousovic K, Konecný K, Mĕstecký J, Tomana M, Novák J.
    Cas Lek Cesk; 2002 Nov 22; 141(23):729-34. PubMed ID: 12650029
    [Abstract] [Full Text] [Related]

  • 3. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Nov 22; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 4. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Nov 22; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 5. Clinical course and treatment of IgA nephropathy.
    Mustonen J, Syrjänen J, Rantala I, Pasternack A.
    J Nephrol; 2001 Nov 22; 14(6):440-6. PubMed ID: 11783599
    [Abstract] [Full Text] [Related]

  • 6. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Nov 22; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 7. [New immunopathogenic aspects of IgA nephropathy].
    Hernando L, González-Cabrero J, García-Hoyo R, Hernando P, Egido J.
    Bull Acad Natl Med; 1990 May 22; 174(5):549-59. PubMed ID: 2249143
    [Abstract] [Full Text] [Related]

  • 8. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
    Yamamoto R, Nagasawa Y, Shoji T, Inoue K, Uehata T, Kaneko T, Okada T, Yamauchi A, Tsubakihara Y, Imai E, Isaka Y, Rakugi H.
    Nephrol Dial Transplant; 2009 Dec 22; 24(12):3686-94. PubMed ID: 19420105
    [Abstract] [Full Text] [Related]

  • 9. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Dec 22; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 10. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun 22; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 11. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS, Györy AZ.
    Medicine (Baltimore); 1994 Mar 22; 73(2):79-102. PubMed ID: 8152367
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb 22; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of IgA nephropathy.
    Wada J, Sugiyama H, Makino H.
    Semin Nephrol; 2003 Nov 22; 23(6):556-63. PubMed ID: 14631563
    [Abstract] [Full Text] [Related]

  • 14. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 22; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 15. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
    van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR.
    Nephrol Dial Transplant; 2004 Oct 22; 19(10):2487-93. PubMed ID: 15252166
    [Abstract] [Full Text] [Related]

  • 16. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov 22; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 17. The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes.
    Zhang JJ, Xu LX, Liu G, Zhao MH, Wang HY.
    Nephrol Dial Transplant; 2008 Jan 22; 23(1):207-12. PubMed ID: 17938148
    [Abstract] [Full Text] [Related]

  • 18. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J.
    Am J Kidney Dis; 2011 Dec 22; 58(6):992-1004. PubMed ID: 21872377
    [Abstract] [Full Text] [Related]

  • 19. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L, Wang L, Huang J, Fan J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb 22; 27(1):227-30. PubMed ID: 20337060
    [Abstract] [Full Text] [Related]

  • 20. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
    Monteiro RC, Leroy V, Launay P, Moura IC, Arcos-Fajardo M, Benhamou M, Haddad E.
    Med Sci (Paris); 2003 Dec 22; 19(12):1233-41. PubMed ID: 14691748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.